Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage

被引：3
|
作者：
Takasaki, Kaoru [1 ]
Hehir, David [2 ,3 ,4 ,5 ]
Raffini, Leslie [6 ,7 ]
Samelson-Jones, Benjamin J. [6 ,7 ,8 ]
Shih, Evelyn [1 ,9 ,10 ,11 ]
Dain, Aleksandra Sarah [1 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol & Oncol, 3615 Civic Ctr Blvd,Room 314E, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA USA
[3] Childrens Hosp Philadelphia, Div Cardiac Crit Care, Philadelphia, PA USA
[4] Univ Penn, Perelman Sch Med, Dept Anesthesia, Philadelphia, PA USA
[5] Univ Penn, Perelman Sch Med, Dept Crit Care, Philadelphia, PA USA
[6] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA USA
[7] Univ Penn, Perelman Sch Med, Philadelphia, PA USA
[8] Raymond G Perelman Ctr Cellular & Mol Therapeut, Philadelphia, PA USA
[9] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA USA
[10] Univ Penn, Dept Neurol, Philadelphia, PA USA
[11] Univ Penn, Dept Pediat, Philadelphia, PA USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷 / 06期
基金：
美国国家卫生研究院;
关键词：
VENOUS THROMBOSIS;
D O I：
10.1002/pbc.29484
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage
    Camille Troyer
    Wesley Nguyen
    Annie Xie
    Dexter Wimer
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 149 - 155
  • [32] Andexanet alfa for the reversal of factor Xa inhibitors
    Favresse, J.
    Hardy, M.
    van Dievoet, M. A.
    Sennesael, A. L.
    Douxfils, J.
    Samama, C. M.
    Vornicu, O.
    Dincq, A. S.
    Lessire, S.
    Mullier, F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (05) : 387 - 397
  • [33] Andexanet Alfa for Factor Xa Inhibitor Reversal
    Shatzel, Joseph J.
    Daughety, Molly M.
    DeLoughery, Thomas G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (25): : 2499 - 2499
  • [34] COMPARISON OF 4F-PCC AND ANDEXANET ALFA FOR REVERSAL OF APIXABAN- AND RIVAROXABAN-ASSOCIATED ICH
    Lipski, Michelle
    Pasciolla, Stacy
    Wojcik, Kevin
    Jankowitz, Brian
    Igneri, Lauren
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 378 - 378
  • [35] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Bradshaw, Paige Garber
    Keegan, Shaun
    Foertsch, Madeline
    Yang, George L.
    Ngwenya, Laura B.
    Srinivasan, Vasisht
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 295 - 300
  • [36] Andexanet alfa after 4-factor PCC administration for intracranial hemorrhage: a case series
    Paige Garber Bradshaw
    Shaun Keegan
    Madeline Foertsch
    George L. Yang
    Laura B. Ngwenya
    Vasisht Srinivasan
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 295 - 300
  • [37] Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report
    Jenniches, Daniel
    Kerns, Abigail F.
    DelBianco, John
    Stripp, Matthew P.
    Philp, Allan S.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (23) : 1722 - 1728
  • [38] ANDEXANET ALFA AFTER 4-FACTOR PCC ADMINISTRATION FOR INTRACRANIAL HEMORRHAGE: A CASE SERIES
    Bradshaw, Paige
    Keegan, Shaun
    Foertsch, Madeline
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 375 - 375
  • [39] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
    Siegal, Deborah M.
    Curnutte, John T.
    Connolly, Stuart J.
    Lu, Genmin
    Conley, Pamela B.
    Wiens, Brian L.
    Mathur, Vandana S.
    Castillo, Janice
    Bronson, Michele D.
    Leeds, Janet M.
    Mar, Florie A.
    Gold, Alex
    Crowther, Mark A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (25): : 2413 - 2424
  • [40] What is the role of andexanet alfa in the reversal of anticoagulant effects?
    Sewell, Jenna Hill
    Williams, LaKeisha
    McKnight, Ellen
    Nguyen, Anthony
    Sarac, Miroslav
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2021, 34 (01): : 8 - 9
12345